This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
With the popular success of diabetes and weight-loss peptide drugs from Novo (e.g. semaglutide/Ozempic), this month features a pair of…
Article
2 months ago ●
3 mins read
A squaramide-containing, insurmountable CCR6 antagonist for ulcerative colitis. PF-07054894 is a potential first-in-class, oral Ph. I clinical candidate targeting the…
molecule
2 months ago ●
6 mins read
In Wednesday's Flash Talk webinar, we covered recent highlights in targeted protein degradation, with lots of great questions from the…
Article
3 months ago ●
2 mins read
This article compiles recent high-profile clinical readouts and related news with small molecules of general interest and structures where they…
Article
3 months ago ●
7 mins read
This article highlights million-dollar molecules that were recently in the news with related patent applications that give clues to their…
Article
3 months ago ●
6 mins read
An oral, potentially CNS-penetrant BTK inhibitor for multiple sclerosis, a reversible pan-KRAS inhibitor, and a squaramide-containing clinical candidate are just…
Article
4 months ago ●
3 mins read
Load More
